n-3 polyunsaturated fatty acid supplementation, monocyte adhesion molecule expression and pro-inflammatory mediators in type 2 diabetes mellitus

Diabetic Medicine

Volumn 18, Issue 1, 2001, Pages 51-58

  Sampson, M J ^a,b,c   Davies, I R ^a,b,c   Brown, J C ^a,b,c   Morgan, V ^a,b,c   Richardson, T ^a,b,c   James, A J ^a,b,c   Sampson, A P ^a,b,c   Hughes, D A ^a,b,c  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Diabetes mellitus; Leukotrienes; Monocyte adhesion molecules; n 3 fatty acids

Indexed keywords

ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; HLA DR ANTIGEN; ICOSAPENTAENOIC ACID; INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE; LEUKOTRIENE B4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; OMEGA 3 FATTY ACID; ORAL ANTIDIABETIC AGENT; PEPTIDOLEUKOTRIENE; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; FEMALE; HUMAN; INFLAMMATION; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ANTIGENS, CD58; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; ENGLAND; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS, NONESTERIFIED; FATTY ACIDS, OMEGA-3; HLA-DR ANTIGENS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LEUKOTRIENE B4; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MIDDLE AGED; MONOCYTES; PLASMINOGEN ACTIVATOR INHIBITOR 1; REFERENCE VALUES;

EID: 0035133426     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2001.00410.x     Document Type: Article

References (40)

1. Immunoregulatory and antiinflammatory effects of n-3 polyunsaturated fatty acids
2. Effects of changes in fat, fish and fibre intakes on death and myocardial infarction: Diet and Reinfarction Trial (DART)
3. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction
4. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction
5. Current concepts in cardiovascular pathology: The role of LDL cholesterol in plaque rupture and stabilisation
6. Coronary plaque disruption
7. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterised by an inflammatory process irrespective of dominant plaque morphology
8. Intercellular adhesion molecule - 1
9. Cell adhesion molecules in coronary artery disease
10. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relative of NIDDM patients and in NIDDM patients
11. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress
12. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control
13. Influence of n-3 polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes and inhibit antigen presentation in vitro
14. Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes
15. Omega 3 fatty acids and endothelial leukocyte adhesion molecules
16. Docosahexaenoic and eicosapentaenoic acids inhibit in vitro human lymphocyte-endothelial cell adhesion
17. Effect of dietary enrichment with eicsapentaenoic acid and docosahexanoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function
18. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids
19. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism
20. Cysteinyl leukotriene D4 induced vascular smooth muscle cell proliferation: A possible role in myointimal hyperplasia
21. Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus
22. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomised, prospective, double-blind, controlled study
23. Fish oil and glycemic control in diabetes. A meta-analysis
24. Effect of omega 3 fatty acid on plasma lipids, cholesterol and lipoprotein fatty acid content in NIDDM patients
25. n-3 polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro
26. A rapid method of total lipid extraction and purification
27. Preparation of milk fat methyl esters in alcoholysis in an essentially non alcoholic solution
28. 4 in coronary artery disease and after coronary artery bypass surgery
29. Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules
30. Control of endothelial leukocyte adhesion molecules by fatty acids
31. Inhibition of phagocyte-endothelium interactions by oxidised fatty acids- a natural antiinflammatory action
32. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte enriched preparation of leukocytes
33. n-3 fatty acid incorporation into LDL particles renders them more susceptible to oxidation in vitro but not necessarily more atherogenic in vivo
34. The effects of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary artery disease
35. Vascular homeostasis, adhesion molecules and macrovascular disease in non-insulin dependent diabetes mellitus
36. Selectins and their ligands: Current concepts and controversies
37. Suppression of cholesteryl ester accumulation in cultures human monocyte derived macrophages by lipooxygenase inhibitors
38. Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals
39. Risk factors for coronary artery disease in non insulin dependent diabetes. UKPDS 23